1-甲基-3-丙基-1H-吡唑-5-羧酸结构式
|
常用名 | 1-甲基-3-丙基-1H-吡唑-5-羧酸 | 英文名 | 1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid |
|---|---|---|---|---|
| CAS号 | 139755-99-0 | 分子量 | 168.19300 | |
| 密度 | 1.19g/cm3 | 沸点 | 330.3ºC at 760mmHg | |
| 分子式 | C8H12N2O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 153.5ºC |
1-甲基-3-丙基-1H-吡唑-5-羧酸用途【用途一】 用于合成Viagra等药物 |
| 中文名 | 1-甲基-3-丙基-1H-吡唑-5-甲酸 |
|---|---|
| 英文名 | 1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid |
| 中文别名 | 1-甲基-3-丙基吡唑-5-羧酸 | 1-甲基-3-丙基吡唑-5-羧酸 | 1-甲基-3-丙基-1H-吡唑-5-羧酸 |
| 英文别名 | 更多 |
| 密度 | 1.19g/cm3 |
|---|---|
| 沸点 | 330.3ºC at 760mmHg |
| 分子式 | C8H12N2O2 |
| 分子量 | 168.19300 |
| 闪点 | 153.5ºC |
| 精确质量 | 168.09000 |
| PSA | 55.12000 |
| LogP | 1.07080 |
| InChIKey | KOABFSONXOOIIH-UHFFFAOYSA-N |
| SMILES | CCCc1cc(C(=O)O)n(C)n1 |
| 蒸汽压 | 6.74E-05mmHg at 25°C |
| 储存条件 | 室温,干燥密封 |
| 分子结构 | 1、 摩尔折射率:45.20 2、 摩尔体积(cm3/mol):141.0 3、 等张比容(90.2K):358.6 4、 表面张力(dyne/cm):41.7 5、 极化率(10-24cm3):17.92 |
| 计算化学 | 1.疏水参数计算参考值(XlogP):1.3 2.氢键供体数量:1 3.氢键受体数量:3 4.可旋转化学键数量:3 5.互变异构体数量:无 6.拓扑分子极性表面积55.1 7.重原子数量:12 8.表面电荷:0 9.复杂度:172 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
| 海关编码 | 2933199090 |
|---|
|
~95%
1-甲基-3-丙基-1H-吡唑-5-羧酸 139755-99-0 |
| 文献:AUSPEX PHARMACEUTICALS, INC. Patent: US2008/194529 A1, 2008 ; Location in patent: Page/Page column 56-57 ; US 20080194529 A1 |
|
~54%
1-甲基-3-丙基-1H-吡唑-5-羧酸 139755-99-0 |
| 文献:Journal of Heterocyclic Chemistry, , vol. 38, # 5 p. 1045 - 1050 |
|
~%
1-甲基-3-丙基-1H-吡唑-5-羧酸 139755-99-0 |
| 文献:Bioorganic and Medicinal Chemistry Letters, , vol. 15, # 17 p. 3900 - 3907 |
|
~%
1-甲基-3-丙基-1H-吡唑-5-羧酸 139755-99-0 |
| 文献:Bioorganic and Medicinal Chemistry Letters, , vol. 6, # 15 p. 1819 - 1824 |
|
~%
1-甲基-3-丙基-1H-吡唑-5-羧酸 139755-99-0 |
| 文献:Journal of Heterocyclic Chemistry, , vol. 38, # 5 p. 1045 - 1050 |
| 1-甲基-3-丙基-1H-吡唑-5-羧酸上游产品 5 | |
|---|---|
| 1-甲基-3-丙基-1H-吡唑-5-羧酸下游产品 7 | |
| 海关编码 | 2933199090 |
|---|---|
| 中文概述 | 2933199090. 其他结构上有非稠合吡唑环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
|
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|
|
实验名称:A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS979
|
|
实验名称:Cell-based high throughput primary assay to identify activators of GPR151
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id:GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify activators of...
来源:The Scripps Research Institute Molecular Screening Center
靶标:N/A
External Id:FBW7_ACT_ALPHA_1536_1X%ACT PRUN
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
来源:The Scripps Research Institute Molecular Screening Center
External Id:MITF_INH_Alpha_1536_1X%INH PRUN
|
| 2-methyl-5-propylpyrazole-3-carboxylic acid |
| MFCD02169703 |
| Methisosildenafil Impurity 14 |